ABS-101 appears to be ABSI’s main drug candidate for IBD. However, ABS-201 for hair loss and ABS-301 for solid tumors offer additional sizeable TAMs if successful. ABSI’s AI models and wet lab ...

Absci (NASDAQ:ABSI) was rising after a media report on a $20M investment by the semiconductor company Advanced Micro Devices (NASDAQ:AMD) in the AI drug creation company. ABSI is trading +43.97% ...

Price Action: ABSI stock is up 23% at $3.96 at the last check on Wednesday. Read Next: Travelers Reports 10% Sales Growth In Q4, Driven by Strong Performance in Earned Premiums Latest Ratings for ABSI ...

Price Action: ABSI shares are trading higher by 44.3% at $4.46 in premarket at the last check Wednesday. Read Next : AMD and Nvidia Overtake Intel in Key Markets, Challenging Its Leadership ...

In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other medical AI stocks. Investments in the global healthcare industry have ramped up ...